Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dollar firms as investors keep eagle eye on Fed guidance

Published 03/16/2021, 09:11 PM
Updated 03/17/2021, 12:30 AM
© Reuters. U.S. One dollar banknotes are seen in front of displayed stock graph in this illustration taken

By Hideyuki Sano and Sagarika Jaisinghani

TOKYO (Reuters) - The U.S. dollar held gains against major currencies on Wednesday as investors looked to the U.S. Federal Reserve's policy meeting for indications it could start rate hikes earlier or let bond yields rise further.

Against the yen, the greenback firmed 0.1% to 109.085 yen, hovering near nine-month highs hit this week. The euro was flat versus the dollar after declining in the past three sessions.

With Fed policymakers expected to forecast the fastest U.S. economic growth in decades in the wake of COVID-19 vaccinations and $1.9 trillion in new stimulus, market participants will be focused on cues that the central bank could start raising interest rates in 2023, earlier than it had said.

"It is likely that the FOMC's economic forecasts will acknowledge the improved growth picture this year, but will continue to show a long road toward conditions consistent with maximum employment that would put sustained pressure on inflation," Morgan Stanley (NYSE:MS) strategist Matthew Hornbach said.

"The Fed being more dovish than expected would suggest U.S. yields and the dollar moving lower in the near term, particularly against risk currencies, but we continue to see upside risks for USD into 2Q."

The dollar index stood at 91.908, having risen for three straight sessions on support mainly from elevated U.S. bond yields. [US/]

The euro changed hands at $1.1902, but the common currency could test last week's 3 1/2-month low of $1.18355 on a possible delay in vaccinations.

Europe's medicines watchdog will release results of its investigation into incidents of bleeding, blood clots and low platelet counts in recipients of AstraZeneca (NASDAQ:AZN)'s coronavirus vaccine on Thursday afternoon.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Depending on the outcome, it could hurt the euro zone's business sentiment further and the euro could face fresh selling pressure on the low vaccination theme," said Daisuke Uno, chief strategist at Sumitomo Mitsui (NYSE:SMFG) Bank.

The British pound was down about 0.1% at $1.3886 in Asian trading on Wednesday. The currency has come under pressure from profit-taking after it hit a near three-year high last month on the back of a fast vaccine roll-out.

Commodity-linked currencies including the Australian dollar, the New Zealand dollar and the Canadian dollar eased slightly against the U.S. dollar, tracking weakness in commodity prices. [MET/L] [O/R]

In the cryptocurrency market, bitcoin fell 2.2% to $55,665.45, slipping further away from a record high of $61,781.83 hit on Saturday.

Latest comments

1)Reuters might think major currencies wait for the USA data, but the world moves forward and take guidance from China now.2) There are millions of people protesting all over the world now against the unsafe vaccines. Sweden never followed the world with lockdowns, hence their current herd immunity works well and they dont need vaccines3) Markets are on idle for a week now, not because of the Fed meetings, but because of silly lockdown talks again
Reuters been top notch spreading bull-Xhy-t fake news
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.